BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
What is the latest Revenue of BAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹303 Cr |
| Mar2025 | ₹339 Cr |
| Mar2024 | ₹304 Cr |
| Mar2023 | ₹281 Cr |
| Mar2022 | ₹251 Cr |
How is Revenue of BAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹303 Cr | -10.65 | |
| Mar2025 | ₹339 Cr | 11.51 | |
| Mar2024 | ₹304 Cr | 8.18 | |
| Mar2023 | ₹281 Cr | 12.25 | |
| Mar2022 | ₹251 Cr | - | |
Compare Revenue of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹171.6 Cr | 5.8% | 26.4% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 5.8% |
26.4% |
24.3% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses